GOVERNMENT COUNSEL, LLC

Lobbying for PRIME THERAPEUTICS · Pharmacy Benefit Management

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Minnesota · Senate · $30,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Health Issues

Consolidated Appropriations Act(CAA)of 2026 (P.L. 119-75); S. 2355-Patients Deserve Price Tag Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.